A detailed history of Gsb Wealth Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Gsb Wealth Management, LLC holds 3,292 shares of MRNA stock, worth $224,777. This represents 0.11% of its overall portfolio holdings.

Number of Shares
3,292
Previous 3,292 -0.0%
Holding current value
$224,777
Previous $350,000 11.43%
% of portfolio
0.11%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$69.51 - $104.43 $228,826 - $343,783
3,292 New
3,292 $327,000
Q2 2023

Aug 08, 2023

BUY
$118.5 - $160.53 $212,352 - $287,669
1,792 New
1,792 $217,000
Q3 2021

Oct 22, 2021

SELL
$221.9 - $484.47 $203,038 - $443,290
-915 Closed
0 $0
Q2 2021

Jul 29, 2021

SELL
$129.91 - $234.98 $990,563 - $1.79 Million
-7,625 Reduced 89.29%
915 $215,000
Q1 2021

May 05, 2021

BUY
$109.18 - $185.98 $932,397 - $1.59 Million
8,540 New
8,540 $1.12 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $26.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Gsb Wealth Management, LLC Portfolio

Follow Gsb Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsb Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gsb Wealth Management, LLC with notifications on news.